跳至主要内容
临床试验/CTRI/2022/07/043875
CTRI/2022/07/043875尚未招募未知

Dyslipidemia management in patients with the first acute coronary event: A retrospective observational EMR based RWE study

Dr Reddys Laboratories Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1 Electronic medical data of Patients with a confirmed diagnosis (either by angiography or clinical findings) of the first ACS event (STEMI [ST elevation myocardial infarction]/NSTEMI [non-ST elevation myocardial infarction]/ unstable angina)
  • 2 Minimum of 12 months of follow-up data post statin therapy initiation
  • 3 Patients initiated statin therapy prior to or post first ACS event
  • 4 Patients considered for initiation/ maintenance/ modification of statin therapy before discharge from hospital

排除标准

  • EMR of Patients with a history of hospital admission for ACS in the past 12 months before the index event , type 1 diabetes mellitus, history of malignancy, patients with active or suspected or with history of hepatic or stage 5 renal disease, history of uncontrolled hypothyroidism, alcohol, or drug abuse, Patients on hormone replacement therapy or oral contraceptives within 3 months of enrollment or pregnant patient

研究者

相似试验

招募中
Unknown
A Clinical study in patients with dyslipidemia to determine the actual status of the percentage of patients achieving the target values for the management of LDL-Cholesterol specified in the Japan Atherosclerosis Society Guidelines for the Prevention of Atherosclerotic Cardiovascular Diseases (2022 edition)Dyslipidemia
JPRN-UMIN000051501TOKYO CENTER CLINIC180
已完成
不适用
A Clinical study in patients with dyslipidemia to determine the status of recognition and the percentage of patients achieving the target values for the management of each lipid parameter specified in the Japan Atherosclerosis Society Guidelines for the Prevention of Atherosclerotic Cardiovascular Diseases (2022 edition), and to follow-up the achievement of the target values by subsequent treatment approaches.Dyslipidemia
JPRN-UMIN000046687Medical Corporation Chiseikai Tokyo Center Clinic350
已完成
2 期
utritional management of patients suffering from the problem of disturbed lipid profile
CTRI/2022/01/039645Ruhi Grewal240
招募中
不适用
Prospective registry study of primary dyslipidemiaHomozygous familial hypercholesterolemia (homo-FH) Heterozygous familial hypercholesterolemia (hetero-FH) Type III Hyperlipoproteinemia Familial chylomicronemia Sitosterolemia Cerebrotendinous xanthomatosis Lecithin cholesterol acyltransferase (LCAT) deficiency Tangier disease Abetalipoproteinemia
JPRN-UMIN000042782ational Cerebral and Cardiovascular Center1,000
招募中
Unknown
CHOLESTEROL MANAGEMENT IN CORONARY ARTERY DISEASE: ATORVASTATIN VERSUS ROSUVASTATIN-WHICH TO CHOOSE?
CTRI/2023/04/051592Prof Rajan Joseph Manjuran
Dyslipidemia management in patients with the first... | 临床试验